Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Arrevus Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Prosthetic knee or hip joint infection
Infected joint spacer
Able to swallow tablets
Able to voluntarily sign the informed consent form
Females of childbearing potential must use an acceptable method of birth control
The joint infection must be attributed to bacterial pathogens sensitive to fusidic acid and rifampin
You may not be if
History of hypersensitivity or intolerability to sodium fusidate (Fucidin®), or to rifampin
Females who are pregnant or lactating
Requirement for significant immunosuppression
Bacteremia
Known cirrhosis or decompensated liver disease
Current treatment for HIV or Hepatitis C
Seizure disorder, requiring anti-convulsants
Clareo Health | Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
